Mirae Asset Global Investments Co., Ltd. Mirum Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,600 shares of MIRM stock, worth $83,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,600
Previous 1,725
7.25%
Holding current value
$83,648
Previous $67,000
1.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MIRM
# of Institutions
195Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$344 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$234 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$180 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$169 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$161 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.92B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...